| NCCN guidelines® insights: B-cell lymphomas, version 5.2021: featured updates to the NCCN guidelines AD Zelenetz, LI Gordon, JE Chang, B Christian, JS Abramson, RH Advani, ... Journal of the National Comprehensive Cancer Network 19 (11), 1218-1230, 2021 | 119 | 2021 |
| Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure SM Smith, J Godfrey, KW Ahn, A DiGilio, S Ahmed, V Agrawal, ... Cancer 124 (12), 2541-2551, 2018 | 73 | 2018 |
| Increasing colon cancer screening in primary care among African Americans RE Myers, R Sifri, C Daskalakis, M DiCarlo, PR Geethakumari, J Cocroft, ... Journal of the National Cancer Institute 106 (12), dju344, 2014 | 73 | 2014 |
| Influence of SLC22A1 rs622342 genetic polymorphism on metformin response in South Indian type 2 diabetes mellitus patients G Umamaheswaran, RG Praveen, SE Damodaran, AK Das, C Adithan Clinical and experimental medicine 15, 511-517, 2015 | 71 | 2015 |
| PARP inhibitors in prostate cancer P Ramakrishnan Geethakumari, MJ Schiewer, KE Knudsen, WK Kelly Current treatment options in oncology 18, 1-16, 2017 | 70 | 2017 |
| Outcomes associated with thiotepa-based conditioning in patients with primary central nervous system lymphoma after autologous hematopoietic cell transplant M Scordo, TP Wang, KW Ahn, Y Chen, S Ahmed, FT Awan, A Beitinjaneh, ... JAMA oncology 7 (7), 993-1003, 2021 | 53 | 2021 |
| Genetic analysis of OCT1 gene polymorphisms in an Indian population G Umamaheswaran, RG Praveen, AS Arunkumar, AK Das, DG Shewade, ... Indian journal of human genetics 17 (3), 164, 2011 | 44 | 2011 |
| Association of reduced-intensity conditioning regimens with overall survival among patients with non-Hodgkin lymphoma undergoing allogeneic transplant N Ghosh, S Ahmed, KW Ahn, M Khanal, C Litovich, M Aljurf, VU Bacher, ... JAMA oncology 6 (7), 1011-1018, 2020 | 43 | 2020 |
| Extramedullary B lymphoblastic leukemia/lymphoma (B-ALL/B-LBL): a diagnostic challenge PR Geethakumari, MS Hoffmann, N Pemmaraju, S Hu, JL Jorgensen, ... Clinical Lymphoma Myeloma and Leukemia 14 (4), e115-e118, 2014 | 37 | 2014 |
| Allogeneic hematopoietic cell transplantation provides effective salvage despite refractory disease or failed prior autologous transplant in angioimmunoblastic T-cell lymphoma … N Epperla, KW Ahn, C Litovich, S Ahmed, M Battiwalla, JB Cohen, P Dahi, ... Journal of Hematology & Oncology 12, 1-11, 2019 | 34 | 2019 |
| Balancing quality, cost, and access during delivery of newer cellular and immunotherapy treatments PR Geethakumari, DP Ramasamy, B Dholaria, J Berdeja, A Kansagra Current hematologic malignancy reports 16 (4), 345-356, 2021 | 33 | 2021 |
| Outcomes of rituximab‐BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation D Jagadeesh, NS Majhail, Y He, KW Ahn, C Litovich, S Ahmed, M Aljurf, ... Cancer 126 (10), 2279-2287, 2020 | 22 | 2020 |
| A phase 2, multicentre, open‐label trial (ACE‐LY‐003) of acalabrutinib in patients with relapsed or refractory marginal zone lymphoma P Strati, M Coleman, R Champion, S Ma, C Patti, MY Levy, IS Lossos, ... British journal of haematology 199 (1), 76-85, 2022 | 20 | 2022 |
| CTX110 allogeneic CRISPR-Cas9-engineered CAR T cells in patients (pts) with relapsed or refractory (R/R) large B-cell lymphoma (LBCL): results from the phase 1 dose escalation … JP McGuirk, CS Tam, N Kröger, PA Riedell, HS Murthy, PJ Ho, ... Blood 140 (Supplement 1), 10303-10306, 2022 | 18 | 2022 |
| The association between EGFR and cMET expression and phosphorylation and its prognostic implication in patients with breast cancer YK Chae, DM Gagliato, SG Pai, B Carneiro, N Mohindra, FJ Giles, ... PLoS One 11 (4), e0152585, 2016 | 18 | 2016 |
| The Evolving Biology of Castration-Resistant Prostate Cancer: Review of Recommendations From the Prostate Cancer Clinical Trials Working Group 3. PR Geethakumari, MS Cookson, WK Kelly Oncology (Williston Park, NY) 30 (2), 187-95, 199, 2016 | 17 | 2016 |
| NCCN Guidelines® insights: B-cell lymphomas, version 6.2023: featured updates to the NCCN guidelines AD Zelenetz, LI Gordon, JS Abramson, RH Advani, B Andreadis, ... Journal of the National Comprehensive Cancer Network 21 (11), 1118-1131, 2023 | 16 | 2023 |
| Complement inhibition with eculizumab for thrombotic microangiopathy rescues a living-donor kidney transplant in a patient with antiphospholipid antibody syndrome PR Geethakumari, P Mille, R Gulati, S Nagalla Transfusion and Apheresis Science 56 (3), 400-403, 2017 | 16 | 2017 |
| Breast implant-associated plasmablastic lymphoma: a case report and discussion of the literature PR Geethakumari, J Markantonis, JL Shah, A Alsuwaidan, I Shahab, ... Clinical Lymphoma Myeloma and Leukemia 19 (10), e568-e572, 2019 | 15 | 2019 |
| Cost-effectiveness analysis of CAR T-cell therapies vs antibody drug conjugates for patients with advanced multiple myeloma KA Kapinos, E Hu, J Trivedi, PR Geethakumari, A Kansagra Cancer Control 30, 10732748221142945, 2023 | 12 | 2023 |
